Based on the available evidence and/or reconstitution of caveolae with the alteration of GLP-1 and NMDA receptor signaling, this could further be a promising treatment strategy for a wide range of cognitive dysfunction associated with various neurodegenerative diseases. The gene discussed is GCG; the disease is neurodegenerative disease.